Wall Street Analysts Think Poseida Therapeutics (PSTX) Could Surge 49.25%: Read This Before Placing a Bet

Shares of Poseida Therapeutics, Inc. (PSTX) have gained 282.9% over the past four weeks to close the last trading session at $9.38, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $14 indicates a potential upside of 49.3%.The mean estimate comprises three short-term price targets with a standard deviation of $5.29. While the lowest estimate of $10 indicates a 6.6% increase from ...